What can we learn from the recent blood glucose lowering megatrials?-Reference-Cited by-同舟云学术

What can we learn from the recent blood glucose lowering megatrials?

Published:2010-09-08 Issue:1 Volume:2 Page:1-5
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:

Author:

Chan Juliana CN

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.2040-1124.2010.00063.x/fullpdf

Reference44 articles.

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N Engl J Med,1998

2. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group;Miettinen;Diabetes Care,1998

3. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey;Sprafka;Diabetes Care,1991

4. Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction on hypertension study (LIFE): a randomised trial against atenolol;Lindholm;Lancet,2002

5. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy;Heart Outcomes Prevention Evaluation (HOPE) Study Investigators;Lancet,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice;Nature Reviews Endocrinology;2022-11-29

2. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney International;2022-11

3. Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019);eBioMedicine;2022-09

4. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial;PLOS Medicine;2021-09-21

5. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region;JAMA Network Open;2021-04-30